Sign in

CIK 0001680048

  • Non-accelerated filer
  • Smaller reporting company

MUSTANG BIO, INC.

Sign in to watch
Ticker
MBIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
473828760
Phone
+1 781-652-4500
Business address
95 SAWYER RD, SUITE 110, WALTHAM, MA, 02453
  1. 4 Grant or award President and CEO acquired 127,000 shares (grant or award)
  2. 4 Grant or award SVP, Fin. & Corp. Controller acquired 36,774 shares (grant or award)
  3. 3 Insider Initial Statement of Ownership
  4. 4 Grant or award SVP, Fin. & Corp. Controller acquired 35,000 shares (grant or award)
  5. 4 Grant or award Director acquired 13,812 shares (grant or award)
  6. 4 Grant or award Director acquired 13,812 shares (grant or award)
  7. 4 Grant or award Director acquired 23,812 shares (grant or award)
  8. 4 Grant or award Director acquired 13,812 shares (grant or award)
  9. 4/A Grant or award Director acquired 10,000 shares (grant or award)
  10. 4 Open-market buy President and CEO bought 28,000 shares at an average $3.71 ($103,927)
  11. 4 Open-market buy Director bought 1,000 shares at $3.96 ($3,960)
  12. 4 Open-market buy VP, Fin. & Corp. Controller bought 2,500 shares at an average $4.20 ($10,497)
  13. 3 Insider Initial Statement of Ownership
  14. 4 Grant or award Director acquired 13,000 shares (grant or award)
  15. 4 Open-market buy Director bought 50,000 shares at $4.41 ($220,500)
  16. 3/A Insider 3/A
  17. 3/A Insider 3/A
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 4 of 5 · 85 filings